This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shisa, H. Articles by Hiai, H. Search for Related Content PubMed PubMed Citation Articles by Shisa, H. Articles by Hiai, H.

Genetically Determined Susceptibility of Fischer 344 Rats to Propylnitrosourea-induced Thymic Lymphomas¹

Department of Pathology, Saitama Cancer Center Research Institute, Ina, Saitama 362 [H. S.], and Laboratory of Experimental Pathology, Aichi Cancer Center Research Institute, Tashiro-cho, Chikusa-ku, Nagoya 464 [H. H.], Japan

Administration of propylnitrosourea p.o. by our protocol induced a high incidence of hematolymphatic neoplasms in all six rat strains studied. Remarkable strain differences in susceptibility to thymic lymphomas were observed. The incidence of thymic lymphomas was high in Fischer 344 (98%) and Wistar/Furth (71%) but low in Sprague-Dawley (29%), ACI/Ms (23%), Donryu (24%), and Long-Evans (10%) strains. Segregation of thymic lymphoma incidence among crosses between highly susceptible Fischer and poorly susceptible Long-Evans rats indicated that the increased susceptibility to thymic lymphomas of Fischer rats was determined by a dominant gene Tls-1 (thymic lymphoma susceptible) and that this gene was linked to the coat color loci, p and c, in Linkage Group I in the order of Tls-1 - c - p. The presence of another independently assorting dominant gene, Tls-2, was also suggested to accelerate the thymic lymphomagenesis. Expression of the group-specific antigen of murine leukemia virus as well as infectious viruses was not detected in nine propylnitrosourea-induced thymic lymphomas of Fischer rats.

¹ Supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Education, Science, and Culture, Japan.

² To whom requests for reprints should be addressed.

Received 4/30/84. Revised 9/10/84. Revised 11/29/84. Accepted 12/27/84.

This article has been cited by other articles:

				J. B. Kirkland Niacin status and treatment-related leukemogenesis Mol. Cancer Ther., April 1, 2009; 8(4): 725 - 732. [Abstract] [Full Text] [PDF]

				J. M. Angel, M. Caballero, and J. DiGiovanni Identification of Novel Genetic Loci Contributing to 12-O-Tetradecanoylphorbol-13-acetate Skin Tumor Promotion Susceptibility in DBA/2 and C57BL/6 Mice Cancer Res., June 1, 2003; 63(11): 2747 - 2751. [Abstract] [Full Text] [PDF]

				A. C. Boyonoski, J. C. Spronck, L. M. Gallacher, R. M. Jacobs, G. M. Shah, G. G. Poirier, and J. B. Kirkland Niacin Deficiency Decreases Bone Marrow Poly(ADP-Ribose) and the Latency of Ethylnitrosourea-Induced Carcinogenesis in Rats J. Nutr., January 1, 2002; 132(1): 108 - 114. [Abstract] [Full Text] [PDF]

				A. C. Boyonoski, L. M. Gallacher, M. M. ApSimon, R. M. Jacobs, G. M. Shah, G. G. Poirier, and J. B. Kirkland Niacin Deficiency in Rats Increases the Severity of Ethylnitrosourea-Induced Anemia and Leukopenia J. Nutr., May 1, 2000; 130(5): 1102 - 1107. [Abstract] [Full Text]

				A. Oyabu, K. Higo, C. Ye, H. Amo, M. Saito, S. Yagyu, H. Morita, K. Maeda, T. Serikawa, M. Takahashi, et al. Genetic Mapping of the Thymoma Susceptible Locus, Tsr1, in BUF/Mna Rats J Natl Cancer Inst, February 3, 1999; 91(3): 279 - 282. [Full Text] [PDF]